ADIL (STOCKS)
Adial Pharmaceuticals, Inc
$1.629300
+0.059300 (+3.78%)
Prev close: $1.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Cary J. Claiborne
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.24M
- Employees
- 7
- P/E (TTM)
- -0.09
- P/B (TTM)
- 0.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-3.07 | $-2.19 | -0.8804 | -40.21% |
|
Sep 2025 (Q3)
|
$-2.00 | $-3.57 | +1.5700 | +43.98% |
|
Jun 2025 (Q2)
|
$-4.50 | $-6.38 | +1.8750 | +29.41% |
|
Mar 2025 (Q1)
|
$-8.50 | $-12.62 | +4.1225 | +32.66% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$177.71K |
| Operating Expenses | $7.80M |
| Research and Development | $2.62M |
| Other Operating Expenses | $5.18M |
| Operating Income/Loss | -$7.80M |
| Income/Loss Before Equity Method Investments | -$7.49M |
| Income/Loss From Continuing Operations After Tax | -$7.98M |
| Income/Loss From Continuing Operations Before Tax | -$7.98M |
| Income/Loss From Equity Method Investments | -$492.13K |
| Net Income/Loss | -$7.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$11.93 |
| Diluted Earnings Per Share | -$11.93 |
| Basic Average Shares | 668,630 |
| Diluted Average Shares | 668,630 |
| Assets | $6.67M |
| Current Assets | $6.18M |
| Noncurrent Assets | $492.48K |
| Intangible Assets | $2.78K |
| Other Non-current Assets | $489.70K |
| Liabilities | $1.40M |
| Current Liabilities | $1.40M |
| Accounts Payable | $655.21K |
| Other Current Liabilities | $741.70K |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.28M |
| Liabilities And Equity | $6.67M |
| Net Cash Flow From Operating Activities | -$6.49M |
| Net Cash Flow From Operating Activities, Continuing | -$6.49M |
| Net Cash Flow From Investing Activities | -$1.98M |
| Net Cash Flow From Investing Activities, Continuing | -$1.98M |
| Net Cash Flow From Financing Activities | $8.47M |
| Net Cash Flow From Financing Activities, Continuing | $8.47M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.98M |
| Other Comprehensive Income/Loss | $0.00 |